Professional Documents
Culture Documents
Use of A Two Tiered Degree
Use of A Two Tiered Degree
Abstract
This manuscript translates the USP Pharmacopeial Mean Kinetic Temperature (MKT) into an
approach that can be applied to temperature excursion management. It also describes and
justifies the use of a two-tiered model that is a conservative estimate of product stability, and it
is simplified through the creation of standardized evaluation tables that the end user can apply in
a simplified manner. Single or multiple excursions can be evaluated by a simple arithmetic
analysis (an example of which can be found at the end of the paper). Tables are provided for
both USP Controlled Room and Controlled Cold Temperature excursion evaluations (CRT and
CCT respectively).
Introduction
In clinical studies, the burden of ensuring that investigational medical products (IMPs),
internally developed or purchased, are properly controlled during the study falls upon the study
originator. Ensuring proper control of the IMP during the clinical trial may include evaluating
potential damage resulting from temperature excursions above the labeled storage conditions
that may occur while the material is in transit or while it is stored at the clinical site. When the
study originator is not the innovator, the amount of information that is available to the study
originator for evaluation of the temperature excursion is limited, providing significant
challenges to provide a timely assessment of the impact of the excursion. The objective of this
proposed process is to provide a standardized approach that can be used to assess and
characterize the magnitude of potential product impact (e.g., degradation). The approach
considers not only the short-term impact but also the impact that may have occurred to
purchased IMPs throughout the shelf-life by applying a Product Life Span (PLS) concept. This
approach considers the impact from the date that the study originator takes control of a
purchased IMP to the expiry date of the IMP by applying the principles of Mean Kinetic
Temperature (MKT). This paper presents a simplified strategy on evaluating temperature
excursions using MKT.
Materials and Methods
Basis for the Mean Kinetic Temperature (MKT) Requirement
For materials with N hours of product's shelf-life, the USP (1–3) requires that
[Equation 1]
Where MKTLimit is the mean kinetic temperature upper limit (e.g., 298.15°K, which is equivalent
to 25°C), ΔH is the heat of activation for the instability mechanism (generally 42 to 125 kJ/mol,
although USP <1160> recommends 83.144 kJ/mol unless a more accurate experimentally
determined value is available), R is the universal gas constant
(0.0083144 kJ mol-1 K-1), and ni is the number of hours spent at the storage temperature
If ΔPt,T is the amount of degradation product generated from a pseudo-zero order kinetic process
during storage for t hours at temperature T, then according to the Arrhenius model, Equation 2
corresponds to
[Equation 3]
ΔPN,MKTLimit ≥ ΔPN–nH,T0 + ΔPnH,TH
Equation 3 shows that the USP requirement (Equation 1) corresponds to a restriction that the
total degradation product generated over the product life, including the effects of temperature
excursions, be no greater than would occur if the product was stored isothermally at MKTLimit.
Thus Equation 1 implies an “excursion cost” that is based on a measure of the additional
amount of a degradation product formed during an excursion above the amount that would be
generated during storage at MKTLimit.
This same logic may be applied to an excursion at another temperature, TL. As a result, we can
establish a relationship between “excursion costs” for products stored at
temperatures TL and TH (TL < TH) for nLand nH hours respectively. These “excursion costs” can
be used to estimate a combination of degree-hour excursion costs for each temperature. Thus,
the relationship between TL and TH will justify the use of a reference temperature (TH) when
establishing a conservative degree-hour cost limit for excursions at some temperature (TL) below
the defined reference temperature. The sections below formally derive the technical arguments
necessary to make such a justification.
The above arguments are based on a pseudo-zero order kinetic process. However, many
processes relevant to pharmaceutical stability are in fact first-order kinetic processes. When the
degradation of a drug is very low (e.g., less than 2%), as is typical for many pharmaceuticals,
both zero and first order processes can be treated as following zero order kinetics (12). This
assumption simplifies the model and permits the arguments discussed previously to be applied
equally to first order processes.
Relating Excursion Costs at Different Excursion Temperatures
Typically, materials are not stored at the MKTLimit (top of the stated storage range) but at a lower
temperature that is within material's labeled storage temperature range (defined as T0, which
may be slightly less than the MKTLimit.) One can measure the “excursion cost” as the additional
degradation product formed during an excursion of nL hours at TL >MKTLimit > T0 as
[Equation 4]
ΔPnL,TL – ΔPNL,T = nL(Ae-ΔH/RTL – (Ae-ΔH/RT0)
Since excursions may occur at multiple elevated temperatures, a reference temperature should
be defined such that TH(40°C for a CRT product) > TL > MKTLimit > T0, which permits the
development of a practical excursion control procedure. In this case, the corresponding
"excursion cost" would be defined as
[Equation 5]
ΔPnH,TH – ΔP(Ae-ΔH/RTH – (Ae-ΔH/RT0)
In order to "translate" an excursion cost from TL to TH, we would equate Equations 4 and 5 to
force the amount of extra degradation product to be the same at both temperatures. Rearranging,
we obtain the following relationship between nH and nL
[Equation 6]
Substituting Equations 7 and 8 into Equation 9, with rearrangement, we must demonstrate that
[Equation 10]
Given typical values for ΔH, R, and temperatures, it can be shown that exp -ΔH/RT is a convex
function with respect to T. Reference to Figure 1 below and Equation 6 illustrate that Equation
11 and, therefore, Equation 9 are true, thereby justifying the use of a reference temperature for
establishing a conservative degree-hour cost limit for excursions that occur at lower
temperatures.
Figure 1: Graphical Representation of e-ΔH/RT as a Function of Temperature.
[Equation 11]
eference Temperature.
Assume that the Product Life Span (PLS) for a package of clinical investigational medicinal
product materials is N hours if stored at a temperature of T0. For a single excursion of nH hours
at an excursion temperature of TH, we can rearrange Equation 2 to obtain
[Equation 12]
The right hand side of Equation 12 thus gives the maximum allowable hours of excursion (nH) at
the reference temperature TH. The corresponding maximum allowable degree-hour excursion
cost (Equation 8) that can be applied at any temperature TL ≤ TH or lower would be
[Equation 13]
Cmax(TH) = nH (TH – T0)
The total of all excursion costs, calculated according to Equation 7, can never exceed this
maximum upper limit over the life of the product.
The Need for Two Reference Temperatures
As indicated above in Equation 9, the procedure as just outlined is conservative in that costs
calculated using Equation 7 at temperatures below TH will overestimate the true degree-hour
excursion cost. The degree of conservatism is greater as the temperature difference
between TH and TL increases. Therefore, it makes sense to establish a double-tiered approach
using two reference temperatures to avoid “overspending” the justified “budget” for a few
degrees of over-temperature excursion that typically occurs. For example, in the case of room
temperature storage, we chose the reference temperatures 30°C and 40°C to
be TL and TH, respectively, which are also key compendial and stability set-points. Thus,
excursions occurring in the range 26–30°C will apply against the 30°C maximum
limit TL calculated using Equations 12 and 13. Excursions occurring in the range 31–40°C will
apply against the 40°C maximum limit THcalculated using Equations 12 and 13. Similarly, for
cold storage, we chose reference temperatures 15°C and 25°C for excursions in the ranges of 9–
15°C, and 16–25°C, respectively.
In order to facilitate accounting for the effects of all excursions in both high and low
temperature ranges, a factor can be derived for converting a TH (e.g., 40 or 25°C) excursion cost
to a TL (e.g., 30 or 15°C) excursion cost. Such a factor may be derived using Equation 6 by
expressing T0, TL, and TH (degrees, K). Then, the conversion factor (called the temperature
burden ratio or TBR) will be
[Equation 14]
It is interesting to note that this ratio does not depend on the total number of hours (N) or on
MKT. The temperature burden ratio (TBR) can be multiplied by the maximum number of
storage hours at TH (e.g., 40°C or 25°C) to obtain the corresponding maximum allowable
number of storage hours at TL (e.g., 30°C or 15°C).
An associated factor, the Degree Hour Conversion Ratio (DHCR), for converting the maximum
number of degree-hours at TH to the corresponding number at TL can be obtained by applying
Equations 7 and 8 to Equation 14:
[Equation 15]
Controlled Room
Parameter Controlled Cold Storage
Temperature
MKTLimit (°C) 25 8
TL (°C) 30 15
TH (°C) 40 25
Note: For the purposes of the mathematical treatment in this paper, T0 was taken as the upper
boundary of the room temperature storage range, a worst-case that is not the typical storage
temperature (further discussion found in the Results section). For example, the USP CRT
storage range is stated to be 20–25°C, so a target for controlled storage might be 22–23°C.
However, USP also allows for cooler storage unless specifically limited by the labeling.
Therefore, a lower target storage temperature is acceptable. In Europe, the European Medicines
Agency (EMA) labeling guidance is similar to USP (i.e., storage not higher than 25°C actual
storage down to any temperature is allowed unless restricted). Since the US and most of Europe
are in International Conference for Harmonisation (ICH) Climatic Zone II regions (MKT not
more than 25°C), the methodology supplied in this paper may be applied to both US and
European IMPs.
Results
In order to use the two-tiered degree-hour cost approach for managing excursions of clinical
IMPs, it is first necessary to establish a table giving the maximum allowable degree-hours at the
maximum temperature of the lower temperature tier (i.e., TL in Table I) for various product
PLSs (N) using Equations 12 and 13. The maximum allowable degree-hours at the maximum
temperature of the upper temperature tier (i.e., TH in Table I) are obtained by the use of
Equations 14 and 15. The use of Equations 14 and 15 is simplified by noting that the DHCR for
this scenario is 1.798 for all PLSs. Using the controlled room temperature (CRT) scenario of
Table I, an example of such a table for a CRT product with a PSL from 15–48 months is given
in Table II.
Table II: Allowable Degree-Hour Costs for Two Tiered Controlled Room Temperature
(CRT) Storage Excursions for a Product with a PSL of 15–48 Months.
# Degree- # Degree-Hours40
# Hours at
# Hours at Hours30 Maximum (15ºC
40°C
30°C [From Maximum (5ºC above 25°C ×
Months Days Hours [Obtained
Equation above 25°C × hours) [Obtained
using TBR and
12] hours) [From using DHCR and
Equation 14]
Eqn 13]a Equation 15]a
a.
An MKTLimit of 25.49°C and T0 of 25.00°C was used to calculate these values, as explained in
the text.
For an example to see how Table I and Table II would be applied, see the Discussion section
below.
Similarly, a set of lookup values for the Controlled Cold Temperature (CCT) storage scenario
found in Table I is given in Table III. The use of Equations 14 and 15 for CCT storage is
simplified by noting that the DHCR for this scenario is 1.979 for all PLSs.
Table III: Allowable Degree-Hour Costs for Two-Tiered Controlled Cold Temperature
(CCT) Storage Excursions for a Product with a PSL of 15–48 Months.
# Degree- # Degree-Hours25
# Hours at
# Hours at Hours15 Maximum (17ºC
25°C
15°C [From Maximum (7°C above 8°C × hours)
Months Days Hours [Obtained
Equation above 8°C × [Obtained using
using TBR and
12] hours) [From DHCR and
Equation 14]
Eqn 13]a Equation 15]a
a.
An MKTLimit of 8.49°C and T0 of 8.00°C was used to calculate these values, as explained in the
text.
Table II and Table II are provided as a convenience for the stated situations. Such lookup tables
can be used by those responsible for making rapid decisions about excursion impacts. Note: If
the date of manufacture is actually known, then the PLS can be taken as the fuller time span,
namely from date of manufacture to the expiry date. It is a good manufacturing practice (GMP)
expectation that if the material was pre-burdened with significant temperature damage, some
compensating adjustment would be made, such as shortening of the expiry date or deeming the
material not suitable for distribution. The MKTLimit of 25.49°C and 8.49°C were used for the
calculations because they are well within the allowed ICH long-term stability chamber
tolerances and they are within the tolerances of the instruments used to measure chambers (1).
In addition, as shown in Figure 1, using a small difference between MKTLimit and T0 coupled with
setting T0 at 25.00°C or 8.00°C represents a conservative approach that is reasonable for
excursions that occur with material stored at temperatures with lower T0 values.
When an excursion occurs, the degree-day cost is calculated using Equation 7. If the excursion
occurs in the upper tier (e.g. 31–40°C or 16–25°C respectively), the degree day cost is corrected
to the lower tier reference temperature (30°C) by multiplying it times the DHCR.
The total of all excursion costs for a given IMP should not exceed the maximum allowable
degree-day limit at the maximum temperature of the lower tier (15 or 30°C, respectively)
without further justification (e.g., if a larger excursion allowance was obtained directly from the
supplier).
Discussion
With the allowable degree-hour cost for CRT (Table II) and CCT (Table III) calculated, IMP
temperature excursions can be quickly evaluated. For example, if an IMP is labeled USP CRT,
it has a Product Life Span (PLS) of 15 months (date of possession to expiry), and an excursion
is reported whereupon the material was stored above 25°C for 10 days, the peak temperature
being 28°C. This is the first excursion. The over-temperature event was in the First-Tier
excursion range of 26–30°C; thus, the allowable degree-hrs 30 is 4,135 (from Table II). The
excursion itself used up [3°C over-temperature][10 days][24 hrs/day] = 720 degree-hrs 30. Note:
To simplify the totaling of actual degree-hours 30 over-temperature on an hour-by-hour basis, the
usual practice often is to take the maximum over-temperature amount recorded during the
excursion and multiply by the hours of the excursion duration as the worst-case; this is the
approach taken in this example. Since 720 is less than 4,135, this material is acceptable. The
amount of degree-hours30 coverage remaining is 4,135 – 720 = 3,415 degree-hrs 30, and any
future over-temperature assessment would be made against this remaining balance. At a later
date, a second excursion takes place on the same material for 13 hours at 35°C. This excursion
is at a higher temperature and fits in the Second Tier excursion range of 31–40°C. One would
calculate the degree-hrs40 for the excursion as follows: [10°C over-exposure][13 hours] = 130
degree-hrs40. Next, this value is multiplied by 1.798 to down-convert it to a First Tier degree-
hrs30 equivalent basis; thus, [130 degree-hrs 40][1.798] = 234 degree-hrs30. The final step is to add
the impact of this excursion to the previous. [720 degree-hrs 30 excursion #1] + [234 degree-
hrs30 current excursion] = 954 degree-hrs30 total damage “cost” to date. Since 954 is less than the
total degree-hrs30 allowable of 4,135, the material is still acceptable. Furthermore, the running
balance is 3,415 – 234 = 3,181 degree-hrs 30. Expressed as a percentage, the amount of over-
temperature coverage remaining is [3,181 / 4,135] x 100 = 76.9%. In other words, only 23.1%
of the starting over-temperature allowance has been used up to date.
Conclusion
By applying the principles of USP Mean Kinetic Temperature (MKT) and knowledge of a
commercial IMPs product life span (PLS), the maximum allowable degree-hours can be
calculated, allowing the impact of the temperature excursion to be readily evaluated. This
approach is applicable to drug products that consist of small molecules and have various label
storage restrictions (e.g., CRT, CCT) associated with them.
Acknowledgment
This study was funded by AbbVie (formerly Abbott). AbbVie participated in the study design,
research, data collection, analysis and interpretation of data, as well as writing, reviewing, and
approving the publication. David LeBlond and David Stroz are former employees of Abbott
Laboratories, currently retired, and may own AbbVie stock/options. Shelly Asmussen and
Dennis Stephens are AbbVie employees and may own AbbVie stock/options.
References
1. International Conference on Harmonization (ICH) Q1A (R2): Stability Testing of New Drug
Substances and Products (Second Revision).
2. USP 36-NF 31 General Information <1079>, "Good Storage and Distribution Practices for Drug
Products," 3.
3. USP 36-NF 31 General Information <1160>, "Pharmaceutical Calculations in Prescription
Compounding", 9-11.
4. USP 36-NF 31 General Notice 10.30.60, "Controlled Room Temperature"
5. USP 36-NF 31 General Notice 10.30.40, "Controlled Cold Temperature"
6. USP 36-NF 31 General Test <659>, "Packaging and Storage Requirements," 2-3.
7. USP 36-NF 31 General Information <1191>, "Stability Considerations in Dispensing Practice,"
3.
8. USP 36-NF 31 General Information <1118>, "Monitoring Devices–Time, Temperature, and
Humidity", 2.
9. Bailey L and Medwick T, "Mean Kinetic Temperature – A concept for Storage of
Pharmaceuticals," Pharmacopeial Forum, 19 (5), 6163-6166, 1993.
10. Kommanaboyina B and Rhodes, C, "Effects of Temperature Excursions on Mean Kinetic
Temperature and Shelf Life," Drug Development and Industrial Pharmacy, 25 (12) 1301-1306,
1999.
11. Okeke C, Bailey L, Medwick T, and Grady L, "Temperature fluctuations during mail order
shipment of pharmaceutical articles using mean kinetic temperature approach," Pharmacopeial
Forum 23(3) 4155-4182, 1997.
12. K.C. Waterman, R.C. Adami, "Accelerated aging: Prediction of chemical stability of
pharmaceuticals," Int. J. Pharm. 293, 101-125, 2005.
Appendix
AbbVie Terms used Throughout the Document.
Term Definition
The nominal storage temperature for the material (CRT ~ 22–23°C and
T0
CCT ~ 5°C)
Temperature Burden Ratio, the factor relating the burden or impact between
TBR
two different temperatures
Product Life Span The span of time in months between when material was acquired and when
(PSL) it expires.